| WB | 1/1000-1/2000 | Human,Mouse,Rat |
| IF | 1/20-1/50 | Human,Mouse,Rat |
| IHC | IHC:1/100-1/200;IHF:1/50-1/200 | Human,Mouse,Rat |
| ICC | 1/50-1/200 | Human,Mouse,Rat |
| FCM | 1/20-1/100 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | CAF; CAF1; CAF1P150; CHAF1A; DCAF1; hp15; P150;;CAF 1 subunit A |
| WB Predicted band size | Calculated MW: 107 kDa ; Observed MW: 150 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | A synthesized peptide derived from human CAF 1 subunit A |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是3篇涉及p150CAF1抗体的代表性文献(内容经简化处理)：
1. **"CAF1 is essential for cell proliferation in human hepatocellular carcinoma"**
- **作者**: Li Y et al. (2018)
- **摘要**: 研究通过p150CAF1抗体检测肝癌组织中CAF1复合体的表达水平，发现其高表达与细胞增殖相关，敲低p150CAF1显著抑制肝癌细胞生长，提示其作为潜在治疗靶点。
2. **"The CCR4-NOT deadenylase complex safeguards embryonic stem cells"**
- **作者**: Yamashita A et al. (2016)
- **摘要**: 使用p150CAF1抗体证实该蛋白在胚胎干细胞中的核心作用，调控mRNA稳定性以维持干性，缺失导致胚胎干细胞分化异常。
3. **"p150CAF1 interacts with intranuclear RNAs in a sequence-specific manner"**
- **作者**: Berthet C et al. (2004)
- **摘要**: 通过免疫共沉淀(p150CAF1抗体)发现该蛋白直接结合特定RNA序列，揭示其在转录后调控中的新功能。
注：p150CAF1在不同文献中可能被称为CNOT6/6L或与CCR4-NOT复合体相关，检索时建议拓展相关关键词。实际引用请核对文献完整性和原始数据。
The p150CAF1 antibody targets the p150 subunit of the CCR4-NOT complex, a highly conserved multi-protein assembly critical for post-transcriptional gene regulation in eukaryotic cells. Originally identified in yeast, the CCR4-NOT complex plays diverse roles in mRNA metabolism, including deadenylation (removal of poly(A) tails), translation repression, and transcriptional regulation. The p150 subunit (also called CNOT1) serves as a scaffold protein that stabilizes the complex and coordinates interactions with other subunits, deadenylases (e.g., CNOT6/6L, CNOT7/8), and RNA-binding proteins.
Studies using p150CAF1 antibodies have been instrumental in elucidating the complex's involvement in cellular processes such as cell cycle progression, stress responses, and differentiation. The antibody is widely used in techniques like immunoprecipitation, Western blotting, and immunofluorescence to investigate CCR4-NOT complex localization, protein interactions, and expression dynamics. Dysregulation of the CCR4-NOT complex, including p150CAF1. has been linked to cancer, neurological disorders, and viral infection responses, making this antibody a valuable tool for both basic research and disease mechanism studies. Commercial p150CAF1 antibodies are typically raised against specific epitopes in human or model organism proteins, with validation across experimental applications.
×
